Skydeck turns research into reality
UC Berkeley’s startup accelerator takes university research discoveries and helps translate them into marketable products.
Bio
O’Reilly Bio chronicles the stories of the biological revolution from academic labs, startup companies, community lab spaces, and all who are inspired to make research and tools collaborative, accessible, low-cost, and efficient.
The future of data storage lies in the foundation of biology
DNA holds the key to storing vast amounts of digital data
Editing our world: CRISPR and the future of genomics
The basic technology behind gene editing and a conversation between Jennifer Doudna and Siddhartha Mukherjee.
Probing the pill box: Repurposing drugs for new treatments
As the cost of developing new drugs rises, researchers are investigating new ways to use existing medicines
What becomes of the broken hearted? Blueprint of a donor-free world using custom heart technologies
Advances in 3D-printing technology have the potential to lower the cost and increase the availability of organ transplants.
HVMN’s better-body biohacking
Learn how biohacking is unlocking human potential.
DARPA and the future of synthetic biology
Learn how the Defense Advanced Research Projects Agency (DARPA) has spurred significant advances in the promising field of synthetic biology.
DUO: Connecting the home to the hospital
New technology is allowing doctors to diagnose and treat heart disease faster and more efficiently.
Clinical trial? There’s an app for that
Several new apps are making it easier for doctors and patients to conduct clinical trials.
Consumer-driven innovation for continuous glucose monitoring in diabetes patients
CGMs are unique in the way consumers have taken it upon themselves to create modifications to medical devices.
FDA regulation defines business strategy in direct-to-consumer genetic testing
The FDA is entering a new era of regulation as whole genome sequencing becomes more accessible to consumers.
SynBioBeta and the current biorevolution
Startups and individuals on the cusp of biological breakthroughs.
Google, venture capital, and biopharma
GV, Google's venture capital arm, is investing in several promising biotechnology startups.
Bioprinting: From a DIY revolution to patients
Bioprinting, a technology that emerged from open source communities, has the potential to improve medical science.
Environmental sensing with recycled materials
Electronic waste is an economic and environmental problem, but citizen scientists can take action by using harvested sensors from discarded electronics.
Time machine for cancer diagnosis
Exciting new genetic testing technology has improved the speed and accuracy of cancer diagnosis.
Where beauty and biotechnology intersect
There’s beauty in biology—and the biotech industry is ready to make a move
The community lab: A student’s door to opportunity
Shreya Thiagarajan describes the invaluable experience she gained while working in a local community lab.
How synthetic biology startups are building the future at RebelBio
The accelerator is helping scientists turn their moonshot visions into viable businesses, fast.
Cancer detection, one slice at a time
New technology is allowing researchers to use digitization to help detect cancer.
IndieBio 2017
A look at the cutting-edge technology featured at the most recent IndieBio Demo Day.
Digital detection: Large-scale ambition built on micro-scale fluidics
Miroculus democratizes early cancer detection with an open research database and a digital microfluidic platform.
Citizen health innovators: Exploring stories of modern health
Everyday citizens are becoming empowered to contribute to modern medical science.
Are worms the future of drug development?
NemaMetrix’s ScreenChip collects live-animal, high-throughput C. elegans elecropharyngeograms (EPGs), which are an indication of overall organism health for drug development.